Attached files
| file | filename |
|---|---|
| EX-99.1 - EX-99.1 - MEDIZONE INTERNATIONAL INC | ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 8, 2015
Medizone International, Inc.
(Exact name of registrant as specified in its charter)
|
Nevada
(State or other jurisdiction
of incorporation)
|
2-93277-D
(Commission
File Number)
|
87-0412648
(IRS Employer
Identification No.)
|
4000 Bridgeway, Suite 401, Sausalito, California 94965
(Address of principal executive offices, Zip Code)
Registrant's telephone number, including area code: (415) 331-0303
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 7.01 Regulation FD Disclosure
On September 8, 2015, Medizone International, Inc. (“Registrant”) issued a press release summarizing recent commercial developments involving Registrant’s patented hospital disinfection system in the Kingdom of Saudi Arabia, including the execution of a letter of intent addressing the distribution of the system in the Kingdom of Saudi Arabia. A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated herein by reference.
The information contained in Item 7.01 of this Current Report shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be incorporated by reference into a filing under the Securities Act of 1933, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
ITEM 9.01 Financial Statements and Exhibits
|
(d)
|
Exhibits
|
The following exhibit is provided as part of the information furnished under Item 7.01 of this Current Report on Form 8-K:
|
Exhibit
|
Description
|
|
|
99.1
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Medizone International, Inc.
|
|||
|
By:
|
/s/ Edwin G. Marshall
|
||
|
Edwin G. Marshall
Chief Executive Officer
|
|||
Date: September 9, 2015